Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127870205> ?p ?o ?g. }
- W2127870205 endingPage "2966" @default.
- W2127870205 startingPage "2959" @default.
- W2127870205 abstract "The objectives of this study were to characterize raltegravir (RAL) population pharmacokinetics in HIV-positive (HIV(+)) and healthy individuals, identify influential factors, and search for new candidate genes involved in UDP glucuronosyltransferase (UGT)-mediated glucuronidation. The pharmacokinetic analysis was performed with NONMEM. Genetic association analysis was performed with PLINK using the relative bioavailability as the phenotype. Simulations were performed to compare once- and twice-daily regimens. A 2-compartment model with first-order absorption adequately described the data. Atazanavir, gender, and bilirubin levels influenced RAL relative bioavailability, which was 30% lower in HIV(+) than in healthy individuals. UGT1A9*3 was the only genetic variant possibly influencing RAL pharmacokinetics. The majority of RAL pharmacokinetic variability remains unexplained by genetic and nongenetic factors. Owing to the very large variability, trough drug levels might be very low under the standard dosing regimen, raising the question of a potential relevance of therapeutic drug monitoring of RAL in some situations." @default.
- W2127870205 created "2016-06-24" @default.
- W2127870205 creator A5007876312 @default.
- W2127870205 creator A5011217027 @default.
- W2127870205 creator A5014858344 @default.
- W2127870205 creator A5016191766 @default.
- W2127870205 creator A5018741814 @default.
- W2127870205 creator A5026635936 @default.
- W2127870205 creator A5036714492 @default.
- W2127870205 creator A5037441803 @default.
- W2127870205 creator A5039652605 @default.
- W2127870205 creator A5046740811 @default.
- W2127870205 creator A5060727310 @default.
- W2127870205 creator A5066398751 @default.
- W2127870205 creator A5066429649 @default.
- W2127870205 creator A5086492009 @default.
- W2127870205 creator A5088187599 @default.
- W2127870205 creator A5091531260 @default.
- W2127870205 date "2012-06-01" @default.
- W2127870205 modified "2023-10-04" @default.
- W2127870205 title "Population Pharmacokinetic Analysis and Pharmacogenetics of Raltegravir in HIV-Positive and Healthy Individuals" @default.
- W2127870205 cites W1974423393 @default.
- W2127870205 cites W1976634586 @default.
- W2127870205 cites W1979937973 @default.
- W2127870205 cites W1985106508 @default.
- W2127870205 cites W1988570950 @default.
- W2127870205 cites W1994404131 @default.
- W2127870205 cites W2004424444 @default.
- W2127870205 cites W2008250282 @default.
- W2127870205 cites W2015171620 @default.
- W2127870205 cites W2017331060 @default.
- W2127870205 cites W2030789661 @default.
- W2127870205 cites W2034273907 @default.
- W2127870205 cites W2049140789 @default.
- W2127870205 cites W2054796653 @default.
- W2127870205 cites W2056596520 @default.
- W2127870205 cites W2072205393 @default.
- W2127870205 cites W2075312453 @default.
- W2127870205 cites W2075531822 @default.
- W2127870205 cites W2077432042 @default.
- W2127870205 cites W2083878136 @default.
- W2127870205 cites W2087005825 @default.
- W2127870205 cites W2091145812 @default.
- W2127870205 cites W2102580822 @default.
- W2127870205 cites W2105681903 @default.
- W2127870205 cites W2106095665 @default.
- W2127870205 cites W2110265421 @default.
- W2127870205 cites W2110755408 @default.
- W2127870205 cites W2110945650 @default.
- W2127870205 cites W2116823219 @default.
- W2127870205 cites W2121592758 @default.
- W2127870205 cites W2124600882 @default.
- W2127870205 cites W2125121305 @default.
- W2127870205 cites W2139178927 @default.
- W2127870205 cites W2141966120 @default.
- W2127870205 cites W2147222542 @default.
- W2127870205 cites W2155635136 @default.
- W2127870205 cites W2158922423 @default.
- W2127870205 cites W2161167378 @default.
- W2127870205 cites W2161633633 @default.
- W2127870205 cites W2161780532 @default.
- W2127870205 cites W2162504674 @default.
- W2127870205 cites W2163866093 @default.
- W2127870205 cites W2165447838 @default.
- W2127870205 cites W2169218167 @default.
- W2127870205 cites W2217105240 @default.
- W2127870205 cites W2312235623 @default.
- W2127870205 doi "https://doi.org/10.1128/aac.05424-11" @default.
- W2127870205 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3370715" @default.
- W2127870205 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22371894" @default.
- W2127870205 hasPublicationYear "2012" @default.
- W2127870205 type Work @default.
- W2127870205 sameAs 2127870205 @default.
- W2127870205 citedByCount "39" @default.
- W2127870205 countsByYear W21278702052012 @default.
- W2127870205 countsByYear W21278702052013 @default.
- W2127870205 countsByYear W21278702052014 @default.
- W2127870205 countsByYear W21278702052015 @default.
- W2127870205 countsByYear W21278702052016 @default.
- W2127870205 countsByYear W21278702052017 @default.
- W2127870205 countsByYear W21278702052018 @default.
- W2127870205 countsByYear W21278702052019 @default.
- W2127870205 countsByYear W21278702052020 @default.
- W2127870205 countsByYear W21278702052021 @default.
- W2127870205 countsByYear W21278702052022 @default.
- W2127870205 crossrefType "journal-article" @default.
- W2127870205 hasAuthorship W2127870205A5007876312 @default.
- W2127870205 hasAuthorship W2127870205A5011217027 @default.
- W2127870205 hasAuthorship W2127870205A5014858344 @default.
- W2127870205 hasAuthorship W2127870205A5016191766 @default.
- W2127870205 hasAuthorship W2127870205A5018741814 @default.
- W2127870205 hasAuthorship W2127870205A5026635936 @default.
- W2127870205 hasAuthorship W2127870205A5036714492 @default.
- W2127870205 hasAuthorship W2127870205A5037441803 @default.
- W2127870205 hasAuthorship W2127870205A5039652605 @default.
- W2127870205 hasAuthorship W2127870205A5046740811 @default.
- W2127870205 hasAuthorship W2127870205A5060727310 @default.
- W2127870205 hasAuthorship W2127870205A5066398751 @default.